Stocks
Codexis, Inc.CDXS
NASDAQHealthcareBiotechnology$1.61-5.85%
Specializing in protein engineering and biocatalysis, this company develops enzymes for pharmaceutical, food, and industrial applications. Investors monitor its partnerships with major pharma firms and potential in sustainable chemistry solutions.
Market Cap: $145.4M52W Range: $0.96 – $3.87
Congressional Interest in Codexis, Inc. (CDXS)
1 member of Congress has disclosed 1 trade in Codexis, Inc. (CDXS), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading CDXS?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2018-04-06 | Lamar Smith | buy | $1K – $15K |